Trial Profile
Therapeutic Efficacy of Triple Combination of Metformin, DPP4 Inhibitor and Thiazolidinedione in Drug-naive Korean Type 2 Diabetic Patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Metformin (Primary) ; Sitagliptin (Primary) ; Thiazolidinediones (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 13 Sep 2018 Status changed from recruiting to completed.
- 06 Oct 2017 Planned number of patients changed from 120 to 200.
- 09 Aug 2017 Planned primary completion date changed from 1 Apr 2017 to 1 Dec 2017.